What happens when the government stops by Covid vaccines?; FDA clears boosters for kids 5-11

The federal government has distributed Covid-19 vaccines and treatments for free so far, but most likely, the handouts won't last forever. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

What happens when the government stops buying Covid-19 vaccines? By Rachel Cohrs Virginia Mayo/AP The federal government has distributed Covid-19 vaccines and treatments for free so far, but most likely, the handouts won't last forever. Read More FDA clears Covid booster shot for healthy kids ages 5 to 11 By Lauran Neergaard — Associated Press Rogelio V. Solis/AP Pfizer's shot is the only Covid vaccine available for U.S. kids. Those 5 to 11 receive one-third of the dose given to everyone 12 and older. Read More STAT+: Life or death decisions and no feedback: New study highlights the value of patient tracking, especially in the ER By Tara Bannow APU GOMES/AFP via Getty Images ER doctors favor tracking their former patients, a new study finds. Proponents say it improves patient care, as long as it’s done ethically. Read More Sponsor content by STAT Events Meet us at The STAT Health Tech Summit Next week, we're hosting a full day of conversations covering all things health tech – from how tech giants are tackling health tech to what it will take to ensure patient data is protected. Meet us in San Francisco, or join us virtually, to be part of these important discussions. Learn more at statnews.com/summit. National Academies report cites 'urgent' need to recruit more diverse participants for clinical trials By Usha Lee McFarling Adobe The authors said funding to include and recruit more diverse participants for clinical trials should be a priority that is enforced. Read More STAT+: High blood pressure pills are costly — but also hard to find — in some lower-income countries By Ed Silverman APStock The ability to control blood pressure, a risk factor for the leading cause of death worldwide, is being hindered, a new report finds. Read More Opinion: Russian aggression underscores the U.S.'s need for greater investment in medical countermeasures By Joe Lieberman and Michelle McMurry-Heath Adobe The U.S. mustn't delay significant investment in innovative chemical, biological, radiological, and nuclear medical countermeasures. Read More Opinion: Omitting long Covid from pandemic messaging is harmful for public health By Danielle Wenner and Gabriela Arguedas Ramírez Adobe Public health narratives neglect long Covid, leading those with symptoms to be discounted, marginalized, and subject to other harms. Read More Tuesday, May 17, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser